Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DITPA in Heart Failure
NCT00032643Phase 2Terminated
- Sponsor
- United States Department of Veterans Affairs
- Start
- Jun 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing DITPA with Placebo (2 arms). Primary endpoints: Composite endpoint of cardiovascular mortality/morbidity, change in NYHA class and change in global assessment at 6 months and Safety at 6 months. Started Jun 2004; status: terminated.
02
Drugs
3,5-diiodothyropropionic acid
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00032643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032643.